Evaluation of the Correlation Between Depression Intensity and Inflammation Levels in Patients with Major Depressive Disorder: A Case-Control Study
Authors:
- Radu GavrilRGRadu Gavril
- Petru-Romeo DobrinPetru-Romeo Dobrin
- Vlad-Teodor IacobVIVlad-Teodor Iacob
- Andreea-Cristina BejenariuABAndreea-Cristina Bejenariu
- Raluca GavrilRGRaluca Gavril
- Alin-Constantin PinzariuAlin-Constantin Pinzariu
- Mihaela MoscaluMMMihaela Moscalu
- Ioana SilistraruISIoana Silistraru
- Cristinel StefanescuCSCristinel Stefanescu
Preprint
- 24 July 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The primary objective of this study is to determine the existence of a significant correlation between inflammation levels, as measured by inflammatory markers IL-6, IL-1β, and TNF-α, and the severity of depressive symptoms assessed using HAM-D assessment scale. This could provide additional evidence supporting the hypothesis that inflammation plays a notable role in the pathogenesis of depression. The data analysis supports the hypothesis that the biological mechanisms of inflammation contributes to the clinical manifestations of depression. Elevated levels of inflammatory markers, especially interleukins (IL6, IL1β), tumor necrosis factor-alpha (TNFα), and C-reactive protein (CRP) have been identified in patients with major depressive disorder compared to the findings in healthy controls. Materials and Methods: Inflammatory markers (IL-6, IL-1β, and TNF-α) were measured in a sample of 31 patients hospitalized at the Socola Institute of Psychiatry in Iasi, Romania, and compared to a control group with no psychiatric or inflammatory conditions. One of the main objectives is to determine if there is a significant correlation between inflammation levels, measured by inflammatory markers (IL-6, IL-1β, and TNF-α), and the severity of depressive symptoms assessed using HAM-D scores. Conclusions: The study results suggest a significant correlation between inflammation levels measured by inflammatory markers IL-1β and IL-6 and the severity of depressive symptoms evaluated by HAM-D scores in the study group. These findings support the hypothesis that inflammation may play an important role in the development or exacerbation of depressive symptoms. The relationship between inflammation and depression is also influenced by risk and protective factors that require further research.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- Introducing a depression-like syndrome for translational neuropsychiatry: a plea for taxonomical validity and improved comparability between humans and miceMolecular Psychiatry, 2022
- Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosisEuropean Neuropsychopharmacology, 2022
- Suicide Biomarkers to Predict Risk, Classify Diagnostic Subtypes, and Identify Novel Therapeutic Targets: 5 Years of Promising ResearchInternational Journal of Neuropsychopharmacology, 2021
- Animal models for the study of depressive disorderCNS Neuroscience & Therapeutics, 2021
- On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?Journal of Neuroinflammation, 2021
- Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controlsBrain, Behavior, and Immunity, 2020
- Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohortBrain, Behavior, and Immunity, 2019
- Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorderBrain, Behavior, and Immunity, 2015
- Astrocytic Hypertrophy in Anterior Cingulate White Matter of Depressed SuicidesNeuropsychopharmacology, 2011
- A prospective evaluation of the directionality of the depression–inflammation relationshipBrain, Behavior, and Immunity, 2009